Discover how Medifast navigates GLP-1 market shifts with innovative products like OPTAVIA ASCEND, cost-saving initiatives, and growth strategies for 2025.

Reports Q4 revenue $119M vs. $191M last year. “This past year was a pivotal year for Medifast (MED), as we continued to transform our business ...

The company expects first quarter 2025 revenue to be in the range of $100 million to $120 million and first quarter 2025 EPS to range from a ...

Shares of Medifast stock opened at $16.19 on Friday. Medifast has a 52-week low of $14.76 and a 52-week high of $52.96. The company has a quick ratio of 2.55, a current ratio of 3.11 and a debt-to ...

Wellness company Medifast (NYSE:MED) in Q4 CY2024, but sales fell by 37.7% year on year to $119 million. On the other hand, ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Medifast (MED) came out with quarterly earnings of $0.10 per share, beating the Zacks Consensus Estimate of a loss of $0.27 per share. This compares to earnings of $1.09 per share a year ago. These ...

In April 2023, the AHA published their ranking of popular diets based on the association's dietary guidance for heart health. And more recently, US News & World Report ranked the best heart ...

All three major U.S. indices are red in Wednesday's midday trading as investors weighed President Donald Trump's proposed tariffs on auto imports, pharmaceuticals and semiconductors.

Some foods can be powerful allies in your fight against chronic diseases and age-related conditions. The Latest The new weight loss drug offers promising results for those who are overweight or ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.